MSB vs NUZ

ASX Healthcare sector comparison — updated 22 Jul 2026 — Healthcare sector

MSB

MESOBLAST FPO [MSB]

41LOW

NUZ

NEURITHERA FPO [NUZ]

50MEDIUM

Score Breakdown

MSB NUZ
Technical
35
42
Catalyst
53
51
Sentiment
50
50
Fundamental
80
48
Momentum
60
36
Risk Gate
40
50

Key Metrics

MSB Metric NUZ
$3.1BMarket Cap$51.2M
4.1MAvg Volume (20d)1.1M
+7.8%Short InterestN/A
$3.31052-Week High$0.185
$1.88052-Week Low$0.055
-4.5%Daily Change-1.5%
$2.320Reference Price$0.064
-18.2%ROE-147.1%
-144.3%Profit Margin-248.4%

Active Signals

MSB Signals

Above-average volume (1.6x) on a red day — sellers in control
Took a hit — down 10.4% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (9 quarters)
Strong revenue growth (+1527%)
EPS estimates revised upward (+10pts)
Director buying detected (1 transactions)
Elevated short interest (7.8%)

NUZ Signals

MACD momentum is losing steam
Drifting lower — down 3.0% over the last 5 days
Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.8 quarters)
Moderate P/S ratio (8.6x)
Strong revenue growth (+290%)
Near 52-week low (8% of range)

Ask Scout AI to compare MSB and NUZ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MSB vs ONE →MSB vs PEB →MSB vs PKP →MSB vs PKY →MSB vs PYC →
MSB Full Analysis → NUZ Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).